NCT02074345View on ClinicalTrials.gov

Phase III Study of Intramuscular TAK-816 in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Healthy VolunteersHaemophilus Influenzae Type b, Prevention
Interventions
BIOLOGICAL

TAK-816

TAK-816 intramuscular injection

Trial Locations (4)

Unknown

Kumagaya-shi

Fuchu-shi

Suginami-ku

Kofu

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY